Bloomberg terminal users will be alerted to issues in clinical trials of new drugs and other events that may move the markets. They will also get analysis of how those issues impact an individual company as well as related companies and markets.
“We’re excited to empower Bloomberg terminal uses with AppliedXL’s well-formulated, real-time news briefings that help them get ahead of the curve,” said Francesco Marconi, co-founder and CEO of AppliedXL, in a statement.
AppliedXL has developed and audited its artificial intelligence in collaboration with journalists who use their expertise to review data, help develop interpretations, and validate the quality of the output during the AI training process.
The AI technology runs an automatic fact-checking process to help decipher accurate information.
Fox Business host Larry Kudlow has no plans to leave his role amid reports detailing…
Morgan Meaker, a senior writer for Wired covering Europe, is leaving the publication after three…
Nick Dunn, who is currently head of CNBC Events as senior vice president and managing…
Wall Street Journal editor in chief Emma Tucker sent out the following on Friday: Dear…
New York Times metro editor Nestor Ramos sent out the following on Friday: We are delighted to…
Rahat Kapur of Campaign looks at the evolution The Wall Street Journal. Kapur writes, "The transformation…